0001127602-22-026326.txt : 20221123
0001127602-22-026326.hdr.sgml : 20221123
20221123145316
ACCESSION NUMBER: 0001127602-22-026326
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220801
FILED AS OF DATE: 20221123
DATE AS OF CHANGE: 20221123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vitoc Vlad
CENTRAL INDEX KEY: 0001913257
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 221415737
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0306
4/A
2022-08-01
2022-08-02
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913257
Vitoc Vlad
444 WEST LAKE STREET,
CHICAGO
IL
60606
1
1
1
Chief Executive Officer
Common Stock
2022-08-01
4
P
0
6000
5.00
A
789121
D
Common Stock
2022-08-01
4
P
0
10000
5.00
A
210000
I
See Footnote
These shares were purchased in the issuer's initial public offering, which closed on August 1, 2022.
These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
/s/ Vlad Vitoc
2022-11-23